G1 Therapeutics, Inc. GTHX 深 滬
已收盤 09-18 16:00:00 美东时间
7.15
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 7.15
- 總市值 3.73亿
- 52周最高 7.19
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.08
- 委 比 0.00%
- 總股本 5219.94万
- 歷史最高 69.57
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.08
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pharmacosmos Acquires G1 Therapeutics, Enhances Cancer Therapy Reach
G1 Therapeutics ( ($GTHX) ) just unveiled an update. Pharmacosmos A/S has final...
2024-09-18 21:47
Small-cap stocks have climbed recently. Here are the ones most poised for further upside
Small cap stocks (NYSEARCA:IWM) are up almost 2% from a month ago. This comes as investors make bets ahead of an expected rate cut from the Federal Reserve. Investors are predicting an aggressive rate...
2024-09-17 04:15
Catalyst Watch: Apple's iPhone event, Oracle earnings, Google antitrust trial, and the August CPI print
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Seeking Alpha's earnings calendar for a full list of companies due to report....
2024-09-07 03:00
快讯 | Pharmacosmos Group和g1 therapeutics宣布Hart-Scott-Rodino等待期已到期。
Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino...
2024-09-05 18:30
美股牛股 | Q2业绩大胜预期！借贷平台Upstart涨39.5%，美光纤股Lumen涨32.6%
AI驱动多家公司业绩超预期增长！借贷平台Upstart隔夜涨39.5%；美光纤股Lumen隔夜涨32.6%，自7月初以来累计涨幅超500%>>
2024-08-08 19:59
G1 Therapeutics Q2 2024 GAAP EPS $(0.10) Beats $(0.17) Estimate, Sales $16.546M Beat $16.363M Estimate
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.17) by 41.18 percent. This is a 171.43 percent decrease over earnings of $0.14 per share from
2024-08-08 18:33
快讯 | g1 therapeutics：具有足够的现金储备以在2025下半年实现预期的公司盈利能力。
G1 Therapeutics: Has Sufficient Cash Runway to Achieve Anticipated Company Prof...
2024-08-08 18:31
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, GTHX, RNST on Behalf of Shareholders
NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2024-08-08 13:12
Needham Downgrades G1 Therapeutics to Hold
Needham analyst Gil Blum downgrades G1 Therapeutics (NASDAQ:GTHX) from Buy to Hold.
2024-08-08 04:09
G1 Therapeutics Acquisition and Executive Compensation Revamp
G1 Therapeutics (GTHX) has issued an announcement. G1 Therapeutics, Inc. has st...
2024-08-07 21:47
